$HBAN

Huntington Bancshares stock falls on lowered guidance outlook

Huntington Bancshares (HBAN) stock dropped 3% after lowering its fiscal 2027 EPS guidance to $1.75-$1.83 from $1.90-$1.93, citing higher rates and competition. 2026 net interest income growth forecast cut to 35% from 39-43%. Fee income growth outlook raised to 32% from 26.5-29.5%. Share repurchases increased to $1.3B-$1.4B.

Original reporting
Published Sep 16, 2026, 11:54 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 11:57 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$HBAN
Bearish
high confidence
Mentioned
$HBAN
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$HBANBearishMed
01

Why it matters

The guidance downgrade reflects moderating net‑interest‑margin expansion and heightened competition, which may signal a broader slowdown for regional banks.

02

Market read

Guidance cut is a fresh, material event for HBAN and could influence peer banks.

03

What to watch

Higher fee‑income growth and a 17%+ ROE target could offset margin concerns.

Relevance 7/10Novelty 7/10Timing: Monday

Background

Huntington Bancshares presented its outlook at the Barclays Global Financial Conference amid a broader market focus on Fed policy.

Company-level read

Ticker impact

$HBANBearishHigh confidence
Context

Huntington Bancshares lowered its FY2027 EPS guidance to $1.75‑$1.83 and cut FY2026 net interest income growth outlook, prompting a 3% share decline.

Expected impact

Further downside pressure if earnings miss expectations; short‑term sell pressure.

Evidence & confidence

Guidance revisions are fresh, material, and directly affect valuation multiples; the market already reacted with a 3% drop.

Market effects

Lowered guidance may weigh on regional banking sector sentiment.

Potential drag on Mid‑West banking stocks.

Limited; primarily a US regional bank effect.

Counterpoint

If the share repurchase program is increased, the stock could find support despite the guidance cut.

Key entities

  • Huntington Bancshares

    U.S. regional bank (NASDAQ:HBAN) reporting lowered earnings guidance.

Related articles

$HBANMed

Stocks fall after Federal Reserve raises interest rates

U.S. stocks fell Wednesday after the Federal Reserve raised interest rates, with the S&P 500 down 0.4% and the Dow Jones dropping 1.2%. Fed Chairman Kevin Warsh indicated more hikes may come as inflation remains high. Traders expect rates to reach 4.25%-4.50% by year-end. Bank stocks declined, while AI-related stocks like Nvidia and AMD rose.

$JPMMed

Major US banks raise prime rate after first Fed rate hike since 2023

Top U.S. banks, including JPMorgan and Bank of America, raised their prime lending rate to 7% after the Federal Reserve's first rate hike since 2023. The Fed increased rates by 0.25% and signaled further hikes, aiming to combat inflation. Bank shares fell, with JPMorgan down 1% and Goldman Sachs down 4%. Higher rates boost bank earnings but may slow economic activity and reduce loan demand.

$HBANHigh

Why is Huntington Bancshares stock sliding today?

Huntington Bancshares (HBAN) stock fell 2.0% to $16.41 in pre-market trading after lowering its fiscal 2027 EPS guidance to $1.75-$1.83, down from $1.90-$1.93, and revising 2026 net interest income growth forecast lower. The bank cited high short-term rates and deposit pricing competition. The stock's ex-dividend date is September 17.

$HBANMed

HBAN Looks 0.2% Undervalued on GF Value™ as Dividend Sustainabil

Huntington Bancshares (HBAN) promoted Brant Standridge to president, potentially positioning him as a future CEO. The company offers a 3.73% dividend yield with a 42% payout ratio, and its stock is fairly valued at $16.62 vs. GF Value™ of $16.66. HBAN has a GF Score™ of 79, with strengths in growth and valuation but weaker financial strength. Insiders have sold more shares than purchased, and institutional investors show mixed sentiment.

$HBANMed

Huntington Bancshares Q2 Earnings Call Highlights

Huntington Bancshares management said it is on track for $365 million in Cadence cost synergies in Q4 and $435 million in combined Veritex and Cadence run-rate expense synergies by Q4. Q2 average loans rose $15B (8.6%) and deposits rose $18.8B (9.2%). Net interest income was $2.1B (+8.5%); value-added fees rose over 60% YoY. Outlook: NII pressured by deposit costs; EPS target for 2027 is $1.90 to $1.93.